146 related articles for article (PubMed ID: 33905855)
1. CLOVES Syndrome Diagnosis and Treatment in an Adult Patient.
Ferreira J; Gutiérrez JCL; Carneiro A; Araújo A; Sousa PP; Braga S; Simões JC; Carrilho C; Mesquita A
Ann Vasc Surg; 2021 Aug; 75():533.e5-533.e9. PubMed ID: 33905855
[TBL] [Abstract][Full Text] [Related]
2. CLOVES syndrome: Treatment with oral Rapamycin. Report of two cases.
de Grazia R; Giordano C; Cossio L; Downey C; Delucchi Á; Kramer D
Rev Chil Pediatr; 2019 Dec; 90(6):662-667. PubMed ID: 32186590
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy in patients with PIK3CA-related overgrowth syndrome.
Venot Q; Blanc T; Rabia SH; Berteloot L; Ladraa S; Duong JP; Blanc E; Johnson SC; Hoguin C; Boccara O; Sarnacki S; Boddaert N; Pannier S; Martinez F; Magassa S; Yamaguchi J; Knebelmann B; Merville P; Grenier N; Joly D; Cormier-Daire V; Michot C; Bole-Feysot C; Picard A; Soupre V; Lyonnet S; Sadoine J; Slimani L; Chaussain C; Laroche-Raynaud C; Guibaud L; Broissand C; Amiel J; Legendre C; Terzi F; Canaud G
Nature; 2018 Jun; 558(7711):540-546. PubMed ID: 29899452
[TBL] [Abstract][Full Text] [Related]
4. What is your diagnosis?
Panteliades M; Silva CM; Gontijo B
An Bras Dermatol; 2016; 91(3):378-80. PubMed ID: 27438212
[TBL] [Abstract][Full Text] [Related]
5. [CLOVES syndrome: a malformational syndrome closely resembling Proteus syndrome].
Guillet A; Aubert H; Tessier MH; David A; Perret C; Penhoat M; Stalder JF; Barbarot S
Ann Dermatol Venereol; 2014; 141(8-9):507-13. PubMed ID: 25209813
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum: A brief report.
Denorme P; Morren MA; Hollants S; Spaepen M; Suaer K; Zutterman N; Labarque V; Legius E; Brems H
Pediatr Dermatol; 2018 May; 35(3):e186-e188. PubMed ID: 29493003
[TBL] [Abstract][Full Text] [Related]
7. CLOVES syndrome.
Bloom J; Upton J
J Hand Surg Am; 2013 Dec; 38(12):2508-12. PubMed ID: 24161472
[TBL] [Abstract][Full Text] [Related]
8. Cloves syndrome: a case report and perinatal diagnostic findings.
Puvabanditsin S; Memon N; Chekmareva M; Di Stefano V; Mehta R
Genet Couns; 2014; 25(3):265-70. PubMed ID: 25365848
[TBL] [Abstract][Full Text] [Related]
9. Alpelisib Treatment for Genital Vascular Malformation in a Patient with Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Spinal/Skeletal Anomalies and/or Scoliosis (CLOVES) Syndrome.
López Gutiérrez JC; Lizarraga R; Delgado C; Martínez Urrutia MJ; Díaz M; Miguel M; Triana P
J Pediatr Adolesc Gynecol; 2019 Dec; 32(6):648-650. PubMed ID: 31330249
[TBL] [Abstract][Full Text] [Related]
10. CLOVE Syndrome.
Kasinathan A; Sankhyan N; Ahuja CK; Singhi P
Indian J Pediatr; 2018 Jan; 85(1):79-80. PubMed ID: 28752282
[No Abstract] [Full Text] [Related]
11. Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal/skeletal abnormalities and Klippel-Trénaunay syndrome.
Reis J; Alomari AI; Trenor CC; Adams DM; Fishman SJ; Spencer SA; Shaikh R; Lillis AP; Surnedi MK; Chaudry G
J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):511-516. PubMed ID: 29909856
[TBL] [Abstract][Full Text] [Related]
12. Fibroadipose hyperplasia versus Proteus syndrome: segmental overgrowth with a mosaic mutation in the PIK3CA gene.
Youssefian L; Vahidnezhad H; Baghdadi T; Ghaznavi A; Li Q; Tabrizi M; Uitto J
J Invest Dermatol; 2015 May; 135(5):1450-1453. PubMed ID: 25602158
[No Abstract] [Full Text] [Related]
13. Segmental overgrowth syndrome due to an activating PIK3CA mutation identified in affected muscle tissue by exome sequencing.
Rasmussen M; Sunde L; Weigert KP; Bogaard PW; Lildballe DL
Am J Med Genet A; 2014 May; 164A(5):1318-21. PubMed ID: 24665065
[TBL] [Abstract][Full Text] [Related]
14. A case of congenital lipomatous overgrowth, vascular malformations, epidermal nevi, spinal/skeletal anomalies and/or scoliosis syndrome with lipoatrophy as an important clinical manifestation.
Schreiber A; Grenier PO; Auger I
Pediatr Dermatol; 2017 Nov; 34(6):735-736. PubMed ID: 28833506
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of a uterine broad ligament leiomyoma in a patient with CLOVES syndrome.
Karpathiou G; Chauleur C; Picot T; Peoc'h M
Pathol Res Pract; 2020 Dec; 216(12):153285. PubMed ID: 33190013
[TBL] [Abstract][Full Text] [Related]
16. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).
Vahidnezhad H; Youssefian L; Uitto J
Exp Dermatol; 2016 Jan; 25(1):17-9. PubMed ID: 26268729
[TBL] [Abstract][Full Text] [Related]
17. Vascular malformations syndromes: an update.
Martinez-Lopez A; Salvador-Rodriguez L; Montero-Vilchez T; Molina-Leyva A; Tercedor-Sanchez J; Arias-Santiago S
Curr Opin Pediatr; 2019 Dec; 31(6):747-753. PubMed ID: 31693582
[TBL] [Abstract][Full Text] [Related]
18. Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
Akgumus G; Chang F; Li MM
J Mol Diagn; 2017 Jul; 19(4):487-497. PubMed ID: 28502730
[TBL] [Abstract][Full Text] [Related]
19. Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
Chang F; Liu L; Fang E; Zhang G; Chen T; Cao K; Li Y; Li MM
J Mol Diagn; 2017 Jul; 19(4):613-624. PubMed ID: 28502725
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Genetic Aspects of the Segmental Overgrowth Spectrum Due to Somatic Mutations in PIK3CA.
Kang HC; Baek ST; Song S; Gleeson JG
J Pediatr; 2015 Nov; 167(5):957-62. PubMed ID: 26340871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
